EyePoint Pharmaceuticals Inc. (EYPT) NASDAQ
$17.57 0.62 (3.66%)
Market Cap: $875.53M
As of 04/23/24 04:00 PM EDT. Market closed.
EyePoint Pharmaceuticals Inc. (EYPT)
NASDAQ
$17.57
0.62 (3.66%)
Market Cap: $875.53M
As of 04/23/24 04:00 PM EDT. Market closed.
Add to Portfolio
psivida corp., (nasdaq: psdv) (asx: pva) headquartered in watertown, ma, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. psivida is currently focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, durasert™ and biosilicon™. the injectable, sustained release ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
CEO Compensation (Base)
$551,359
CEO Compensation (Total)
$2.17M
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
Full Time Employees
157
CEO Compensation (Base)
$551,359
CEO Compensation (Total)
$2.17M
URL
Address
.
PRICE CHART FOR EYEPOINT PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$16.95
Days Range
$17.55 - $18.68
52 week range
$5.67 - $30.99
Volume
861,886
Avg. Volume (30 days)
872,104
Market Cap
$875.53M
Dividend Yield
-
P/E
-
Shares Outstanding
49,830,792
Open
-
Previous Close
$16.95
Days Range
$17.55 - $18.68
52 week range
$5.67 - $30.99
Volume
861,886
Avg. Volume (30 days)
872,104
Market Cap
$875.53M
Dividend Yield
-
P/E
-
Shares Outstanding
49,830,792
FINANCIAL STATEMENTS FOR EYEPOINT PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR EYEPOINT PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Cormorant Asset Management, LP | 10% Owner | Apr 18, 2024 | Buy | $18.03 | 581,765 | 10,489,446 | 7,475,000 | Apr 22, 2024, 04:00 PM |
| Paggiarino Dario A. | Chief Medical Officer | Mar 30, 2024 | Option Exercise | $20.67 | 25,546 | 528,036 | 77,133 | Apr 02, 2024, 05:27 PM |
| Lurker Nancy | Executive Vice Chair | Feb 09, 2024 | Option Exercise | $28.80 | 14,943 | 430,358 | 165,013 | Feb 13, 2024, 05:40 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2024 | Option Exercise | $28.80 | 5,083 | 146,390 | 44,787 | Feb 13, 2024, 05:39 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2024 | Option Exercise | $28.80 | 3,656 | 105,293 | 46,617 | Feb 13, 2024, 05:38 PM |
| Elston George | Chief Financial Officer | Feb 09, 2024 | Option Exercise | $28.80 | 3,192 | 91,930 | 45,065 | Feb 13, 2024, 05:38 PM |
| Duker Jay S. | President and CEO | Feb 09, 2024 | Option Exercise | $28.80 | 3,533 | 101,750 | 53,378 | Feb 13, 2024, 05:37 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 02, 2024 | Option Exercise | $11.47 | 209 | 2,397 | 38,171 | Feb 05, 2024, 05:15 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 02, 2024 | Sale | $28.49 | 209 | 5,954 | 37,962 | Feb 05, 2024, 05:15 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 26, 2024 | Option Exercise | $13.06 | 49,325 | 644,047 | 85,830 | Jan 30, 2024, 04:53 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 26, 2024 | Sale | $25.66 | 49,325 | 1,265,539 | 85,779 | Jan 30, 2024, 04:53 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 26, 2024 | Option Exercise | $6.82 | 26,017 | 177,398 | 63,979 | Jan 29, 2024, 05:54 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 26, 2024 | Sale | $25.38 | 26,017 | 660,370 | 47,566 | Jan 29, 2024, 05:54 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 25, 2024 | Option Exercise | $13.01 | 600 | 7,809 | 37,105 | Jan 29, 2024, 05:51 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 25, 2024 | Sale | $25.00 | 600 | 15,000 | 36,805 | Jan 29, 2024, 05:51 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 24, 2024 | Option Exercise | $8.04 | 11,300 | 90,822 | 49,262 | Jan 26, 2024, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 25, 2024 | Option Exercise | $8.08 | 600 | 4,848 | 38,562 | Jan 26, 2024, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 25, 2024 | Sale | $25.00 | 600 | 15,000 | 38,262 | Jan 26, 2024, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 24, 2024 | Sale | $25.01 | 11,300 | 282,621 | 43,562 | Jan 26, 2024, 05:03 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 24, 2024 | Option Exercise | $13.01 | 11,251 | 146,426 | 47,756 | Jan 25, 2024, 06:26 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 23, 2024 | Option Exercise | $13.04 | 5,135 | 66,954 | 41,640 | Jan 25, 2024, 06:26 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 24, 2024 | Sale | $25.01 | 11,251 | 281,415 | 42,156 | Jan 25, 2024, 06:26 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 23, 2024 | Sale | $25.00 | 5,135 | 128,375 | 39,601 | Jan 25, 2024, 06:26 PM |
| Lurker Nancy | Executive Vice Chair | Jan 24, 2024 | Sale | $24.98 | 29,956 | 748,250 | 135,441 | Jan 25, 2024, 06:24 PM |
| Lurker Nancy | Executive Vice Chair | Jan 23, 2024 | Sale | $24.97 | 5,044 | 125,950 | 165,397 | Jan 25, 2024, 06:24 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 23, 2024 | Option Exercise | $7.54 | 900 | 6,790 | 38,862 | Jan 24, 2024, 04:50 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 22, 2024 | Option Exercise | $10.34 | 34,166 | 353,359 | 72,128 | Jan 24, 2024, 04:50 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 23, 2024 | Sale | $25.00 | 900 | 22,500 | 38,462 | Jan 24, 2024, 04:50 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 22, 2024 | Sale | $22.62 | 34,166 | 772,691 | 66,712 | Jan 24, 2024, 04:50 PM |
| Ocumension Therapeutics | Director | Jan 11, 2024 | Sale | $19.45 | 1,910,500 | 37,159,226 | 100,221 | Jan 16, 2024, 06:55 PM |
| Liu Ye | Director | Jan 11, 2024 | Sale | $19.45 | 1,910,500 | 37,159,226 | 100,221 | Jan 16, 2024, 06:01 PM |
| Cormorant Asset Management, LP | 10% Owner | Jan 11, 2024 | Buy | $19.75 | 750,000 | 14,812,500 | 6,893,235 | Jan 11, 2024, 04:00 PM |
| Cormorant Asset Management, LP | 10% Owner | Jan 09, 2024 | Buy | $21.32 | 105,000 | 2,238,600 | 6,143,235 | Jan 11, 2024, 04:00 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 08, 2024 | Option Exercise | $3.26 | 22,913 | 74,696 | 59,418 | Jan 10, 2024, 04:53 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 08, 2024 | Sale | $21.13 | 22,913 | 484,124 | 36,505 | Jan 10, 2024, 04:53 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,487 | 91,535 | 36,505 | Jan 09, 2024, 09:28 PM |
| Lurker Nancy | Executive Vice Chair | Jan 06, 2024 | Option Exercise | $20.40 | 23,043 | 470,077 | 170,441 | Jan 09, 2024, 09:17 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Jan 06, 2024 | Option Exercise | $20.40 | 5,966 | 121,706 | 13,662 | Jan 09, 2024, 09:11 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,147 | 84,599 | 37,962 | Jan 09, 2024, 09:09 PM |
| Duker Jay S. | President and CEO | Jan 06, 2024 | Option Exercise | $20.40 | 6,528 | 133,171 | 43,486 | Jan 09, 2024, 09:07 PM |
| Elston George | Chief Financial Officer | Jan 06, 2024 | Option Exercise | $20.40 | 4,911 | 100,184 | 35,308 | Jan 09, 2024, 09:04 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 13, 2023 | Option Exercise | $10.13 | 1,458 | 14,770 | 27,165 | Dec 15, 2023, 05:14 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 13, 2023 | Sale | $20.00 | 1,458 | 29,160 | 25,707 | Dec 15, 2023, 05:14 PM |
| Cormorant Asset Management, LP | 10% Owner | Dec 08, 2023 | Buy | $17.00 | 588,235 | 9,999,995 | 6,038,235 | Dec 12, 2023, 04:52 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Option Exercise | $12.62 | 45,000 | 567,900 | 50,343 | Dec 11, 2023, 04:15 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Sale | $21.97 | 46,000 | 1,010,790 | 5,343 | Dec 11, 2023, 04:15 PM |
| Ocumension Therapeutics | Director | Dec 06, 2023 | Sale | $18.41 | 266,242 | 4,901,515 | 2,010,721 | Dec 07, 2023, 09:21 PM |
| Ocumension Therapeutics | Director | Dec 05, 2023 | Sale | $19.91 | 733,758 | 14,609,122 | 2,276,963 | Dec 07, 2023, 09:21 PM |
| Liu Ye | Director | Dec 06, 2023 | Sale | $18.41 | 266,242 | 4,901,515 | 2,010,721 | Dec 07, 2023, 09:03 PM |
| Liu Ye | Director | Dec 05, 2023 | Sale | $19.91 | 733,758 | 14,609,122 | 2,276,963 | Dec 07, 2023, 09:03 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Option Exercise | $12.62 | 45,000 | 567,900 | 50,343 | Dec 06, 2023, 05:20 PM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Dec 04, 2023 | Sale | $22.00 | 45,000 | 990,000 | 5,343 | Dec 06, 2023, 05:20 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 04, 2023 | Option Exercise | $10.13 | 30,625 | 310,231 | 56,332 | Dec 06, 2023, 05:19 PM |
| Paggiarino Dario A. | Chief Medical Officer | Dec 04, 2023 | Sale | $22.00 | 30,625 | 673,750 | 25,707 | Dec 06, 2023, 05:19 PM |
| Lurker Nancy | Executive Vice Chair | Dec 04, 2023 | Sale | $20.76 | 20,000 | 415,200 | 170,559 | Dec 06, 2023, 05:18 PM |
| Cormorant Asset Management, LP | 10% Owner | Dec 04, 2023 | Buy | $21.82 | 1,919,057 | 41,874,150 | 5,450,000 | Dec 06, 2023, 04:39 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Sep 01, 2023 | Sale | $9.90 | 20,000 | 197,982 | 3,490,921 | Sep 06, 2023, 07:10 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Sep 01, 2023 | Sale | $9.90 | 20,000 | 197,982 | 3,490,921 | Sep 06, 2023, 05:14 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 31, 2023 | Sale | $10.24 | 78,495 | 804,061 | 3,517,938 | Sep 01, 2023, 04:51 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 30, 2023 | Sale | $10.92 | 60,976 | 666,147 | 3,589,743 | Sep 01, 2023, 04:51 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 29, 2023 | Sale | $10.75 | 87,854 | 944,225 | 3,650,957 | Aug 30, 2023, 05:46 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 28, 2023 | Sale | $11.71 | 60,858 | 712,653 | 3,738,246 | Aug 30, 2023, 05:46 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 25, 2023 | Sale | $11.00 | 84,656 | 931,327 | 3,810,835 | Aug 30, 2023, 05:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 24, 2023 | Sale | $11.17 | 139,280 | 1,556,155 | 3,935,940 | Aug 30, 2023, 05:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 25, 2023 | Sale | $11.00 | 84,656 | 931,479 | 3,853,760 | Aug 28, 2023, 06:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 24, 2023 | Sale | $14.62 | 139,280 | 2,036,093 | 3,883,760 | Aug 28, 2023, 06:32 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 23, 2023 | Sale | $13.05 | 121,103 | 1,580,915 | 4,023,040 | Aug 24, 2023, 05:30 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Aug 22, 2023 | Sale | $14.62 | 46,778 | 683,834 | 4,144,143 | Aug 24, 2023, 05:30 PM |
| Liu Ye | Director | May 30, 2023 | Sale | $6.00 | 1 | 6 | 3,010,721 | May 31, 2023, 05:22 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2023 | Option Exercise | $4.17 | 3,744 | 15,612 | 27,429 | Feb 13, 2023, 05:07 PM |
| Duker Jay S. | President and COO | Feb 09, 2023 | Option Exercise | $4.17 | 4,148 | 17,297 | 30,943 | Feb 13, 2023, 05:03 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2023 | Option Exercise | $4.17 | 2,956 | 12,327 | 26,606 | Feb 13, 2023, 05:02 PM |
| Duker Jay S. | Chief Operating Officer | Nov 01, 2022 | Option Exercise | $5.42 | 4,479 | 24,276 | 21,402 | Nov 03, 2022, 08:38 AM |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | Mar 14, 2022 | Buy | $12.21 | 1,000 | 12,210 | 1,000 | Mar 15, 2022, 04:21 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,130 | 11,243 | 15,599 | Mar 02, 2022, 06:22 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2022 | Option Exercise | $9.95 | 1,294 | 12,875 | 18,651 | Mar 02, 2022, 06:21 PM |
| Elston George | Chief Financial Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,721 | 17,434 | 9,602 | Feb 11, 2022, 04:41 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,721 | 17,434 | 15,840 | Feb 11, 2022, 04:39 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 09, 2022 | Option Exercise | $10.13 | 1,473 | 14,921 | 12,624 | Feb 11, 2022, 04:39 PM |
| Lurker Nancy | President & CEO | Nov 15, 2021 | Sale | $20.15 | 10,000 | 201,480 | 103,546 | Nov 17, 2021, 05:03 PM |
| Paggiarino Dario A. | Chief Medical Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,423 | 15,383 | 11,592 | Mar 02, 2021, 07:26 PM |
| Jones David Scott | SVP & Chief Commercial Officer | Feb 28, 2021 | Option Exercise | $10.81 | 1,702 | 18,399 | 7,380 | Mar 02, 2021, 07:25 PM |
| Elston George | Chief Financial Officer | Sep 04, 2020 | Buy | $0.48 | 10,000 | 4,800 | 40,000 | Sep 09, 2020, 09:16 AM |
| Elston George | Chief Financial Officer | Aug 24, 2020 | Buy | $0.61 | 10,000 | 6,112 | 30,000 | Aug 26, 2020, 09:21 AM |
| Jones David Scott | SVP & Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $0.76 | 14,060 | 10,643 | 26,990 | Jul 02, 2020, 06:15 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 30, 2020 | Option Exercise | $0.76 | 12,049 | 9,121 | 89,144 | Jul 02, 2020, 06:14 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2020 | Option Exercise | $0.79 | 2,936 | 2,317 | 60,143 | Jun 30, 2020, 07:52 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2020 | Option Exercise | $0.83 | 4,168 | 3,441 | 53,079 | Jun 16, 2020, 05:00 PM |
| Elston George | Chief Financial Officer | Mar 12, 2020 | Buy | $0.96 | 10,000 | 9,600 | 20,000 | Mar 13, 2020, 08:41 AM |
| Lurker Nancy | President & CEO | Mar 10, 2020 | Buy | $1.06 | 98,000 | 104,027 | 574,800 | Mar 11, 2020, 08:40 AM |
| Elston George | Chief Financial Officer | Nov 15, 2019 | Buy | $1.43 | 10,000 | 14,290 | 10,000 | Nov 18, 2019, 08:42 AM |
| Lurker Nancy | President & CEO | Oct 12, 2019 | Option Exercise | $2.11 | 10,745 | 22,618 | 314,455 | Oct 15, 2019, 06:04 PM |
| Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2019 | Option Exercise | $2.11 | 2,450 | 5,157 | 43,047 | Oct 15, 2019, 06:03 PM |
| Mazzo David J | Director | Oct 09, 2019 | Option Exercise | $1.95 | 33,333 | 64,999 | 200,083 | Oct 11, 2019, 06:13 PM |
| Ross Leonard S | See Remarks | Jun 27, 2019 | Option Exercise | $1.65 | 1,961 | 3,236 | 90,044 | Jun 28, 2019, 05:04 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2019 | Option Exercise | $1.65 | 2,940 | 4,851 | 45,497 | Jun 28, 2019, 05:04 PM |
| Ross Leonard S | See Remarks | Jun 14, 2019 | Option Exercise | $1.53 | 2,394 | 3,663 | 85,338 | Jun 17, 2019, 05:41 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 14, 2019 | Option Exercise | $1.53 | 4,175 | 6,388 | 38,437 | Jun 17, 2019, 05:40 PM |
| Landis John B. | Director | May 13, 2019 | Buy | $1.74 | 40,000 | 69,600 | 40,000 | May 15, 2019, 04:55 PM |
| Duker Jay S. | Director | Apr 12, 2019 | Option Exercise | $1.77 | 20,000 | 35,400 | 37,500 | Apr 16, 2019, 08:16 AM |
| Duker Jay S. | Director | Apr 01, 2019 | Buy | $1.89 | 5,000 | 9,450 | 17,500 | Apr 03, 2019, 08:25 AM |
| Ross Leonard S | See Remarks | Apr 01, 2019 | Option Exercise | $1.81 | 5,000 | 9,050 | 79,452 | Apr 02, 2019, 08:24 AM |
| Lurker Nancy | President & CEO | Mar 29, 2019 | Buy | $1.76 | 28,500 | 50,246 | 240,200 | Apr 01, 2019, 08:23 AM |
| Mazzo David J | Director | Mar 29, 2019 | Option Exercise | $1.77 | 20,000 | 35,400 | 158,000 | Apr 01, 2019, 08:21 AM |
| Godshall Douglas Evan | Director | Mar 29, 2019 | Buy | $1.75 | 17,000 | 29,784 | 29,500 | Apr 01, 2019, 08:20 AM |
| Paggiarino Dario A. | Chief Medical Officer | Mar 19, 2019 | Option Exercise | $2.47 | 1,188 | 2,934 | 28,412 | Mar 21, 2019, 05:24 PM |
| Ross Leonard S | See Remarks | Mar 19, 2019 | Option Exercise | $2.47 | 1,735 | 4,285 | 74,452 | Mar 21, 2019, 05:22 PM |
| Ross Leonard S | See Remarks | Dec 22, 2018 | Option Exercise | $1.65 | 18,522 | 30,561 | 76,187 | Dec 26, 2018, 04:06 PM |
| ROGERS MICHAEL W | Director | Nov 15, 2018 | Option Exercise | $1.13 | 100,000 | 113,000 | 112,500 | Nov 16, 2018, 04:00 PM |
| Ross Leonard S | See Remarks | Oct 12, 2018 | Option Exercise | $3.23 | 2,945 | 9,512 | 31,817 | Oct 16, 2018, 04:00 PM |
| Paggiarino Dario A. | Chief Medical Officer | Oct 12, 2018 | Option Exercise | $3.23 | 2,455 | 7,930 | 29,600 | Oct 16, 2018, 04:00 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Jun 25, 2018 | Buy | $1.26 | 652,244 | 825,089 | 25,470,390 | Jul 03, 2018, 06:23 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Jun 25, 2018 | Buy | $1.26 | 16,211,822 | 20,507,955 | 25,470,390 | Jul 03, 2018, 06:23 PM |
| Ross Leonard S | See Remarks | Jun 27, 2018 | Option Exercise | $1.86 | 1,904 | 3,541 | 14,762 | Jun 29, 2018, 04:01 PM |
| Paggiarino Dario A. | Chief Medical Officer | Jun 27, 2018 | Option Exercise | $1.86 | 2,945 | 5,478 | 15,388 | Jun 29, 2018, 04:00 PM |
| Mazzo David J | Director | Apr 20, 2018 | Option Exercise | $1.13 | 120,000 | 135,600 | 120,500 | Apr 24, 2018, 04:00 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Mar 28, 2018 | Buy | $1.10 | 332,863 | 366,149 | 8,606,324 | Apr 02, 2018, 01:02 PM |
| EW Healthcare Partners, L.P. | 10% Owner | Mar 28, 2018 | Buy | $1.10 | 8,273,461 | 9,100,807 | 8,606,324 | Apr 02, 2018, 01:02 PM |
| Lurker Nancy | President and CEO | Jun 14, 2017 | Buy | $1.76 | 56,700 | 99,962 | 56,700 | Jun 14, 2017, 04:05 PM |
| Ashton Paul | President & CEO | Mar 18, 2016 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Mar 22, 2016, 12:24 PM |
| Ross Leonard S | Vice President, Finance | Jan 04, 2016 | Option Exercise | $1.81 | 5,000 | 9,050 | 5,000 | Jan 05, 2016, 05:51 PM |
| Ross Leonard S | Vice President, Finance | Jan 04, 2016 | Sale | $4.70 | 5,000 | 23,500 | 0 | Jan 05, 2016, 05:51 PM |
| Ross Leonard S | Vice President, Finance | Dec 22, 2015 | Option Exercise | $1.81 | 33,950 | 61,449 | 33,950 | Dec 23, 2015, 06:10 PM |
| Ross Leonard S | Vice President, Finance | Dec 22, 2015 | Sale | $5.39 | 33,950 | 182,990 | 0 | Dec 23, 2015, 06:10 PM |
| Ashton Paul | President & CEO | Dec 22, 2015 | Option Exercise | $1.13 | 120,000 | 135,600 | 560,741 | Dec 23, 2015, 06:04 PM |
| Ashton Paul | President & CEO | Dec 22, 2015 | Sale | $5.39 | 120,000 | 646,800 | 440,741 | Dec 23, 2015, 06:04 PM |
| Ross Leonard S | Vice President, Finance | Dec 01, 2015 | Option Exercise | $1.81 | 1,050 | 1,900 | 1,050 | Dec 03, 2015, 03:58 PM |
| Ross Leonard S | Vice President, Finance | Dec 01, 2015 | Sale | $4.06 | 1,050 | 4,263 | 0 | Dec 03, 2015, 03:58 PM |
| Ross Leonard S | Vice President, Finance | Aug 03, 2015 | Option Exercise | $1.81 | 5,000 | 9,050 | 5,000 | Aug 04, 2015, 07:01 PM |
| Ross Leonard S | Vice President, Finance | Aug 03, 2015 | Sale | $4.05 | 5,000 | 20,250 | 0 | Aug 04, 2015, 07:01 PM |
| Ashton Paul | President & CEO | Oct 01, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Oct 03, 2014, 10:44 AM |
| Ashton Paul | President & CEO | Oct 01, 2014 | Sale | $4.27 | 10,000 | 42,700 | 440,741 | Oct 03, 2014, 10:44 AM |
| Ashton Paul | President & CEO | Sep 02, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Sep 03, 2014, 07:07 PM |
| Ashton Paul | President & CEO | Sep 02, 2014 | Sale | $4.78 | 10,000 | 47,800 | 440,741 | Sep 03, 2014, 07:07 PM |
| Ashton Paul | President & CEO | Aug 01, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Aug 04, 2014, 06:17 PM |
| Ashton Paul | President & CEO | Aug 01, 2014 | Sale | $4.37 | 10,000 | 43,700 | 440,741 | Aug 04, 2014, 06:17 PM |
| Ashton Paul | President & CEO | Jul 01, 2014 | Option Exercise | $1.13 | 10,000 | 11,300 | 450,741 | Jul 02, 2014, 05:56 PM |
| Ashton Paul | President & CEO | Jul 01, 2014 | Sale | $4.32 | 10,000 | 43,200 | 440,741 | Jul 02, 2014, 05:56 PM |
| Ashton Paul | President & CEO | Jun 18, 2014 | Option Exercise | $1.13 | 3,931 | 4,442 | 444,672 | Jun 20, 2014, 11:09 AM |
| Ashton Paul | President & CEO | Jun 19, 2014 | Option Exercise | $1.13 | 3,069 | 3,468 | 443,810 | Jun 20, 2014, 11:09 AM |
| Ashton Paul | President & CEO | Jun 18, 2014 | Sale | $4.00 | 3,931 | 15,724 | 440,741 | Jun 20, 2014, 11:09 AM |
| Ashton Paul | President & CEO | Jun 19, 2014 | Sale | $4.00 | 3,069 | 12,276 | 440,741 | Jun 20, 2014, 11:09 AM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 16, 2014 | Option Exercise | $1.81 | 3,436 | 6,219 | 99,859 | Jun 18, 2014, 05:17 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 17, 2014 | Option Exercise | $1.81 | 4,464 | 8,080 | 100,887 | Jun 18, 2014, 05:17 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 17, 2014 | Sale | $4.00 | 4,464 | 17,856 | 96,423 | Jun 18, 2014, 05:17 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 16, 2014 | Sale | $4.01 | 3,436 | 13,778 | 96,423 | Jun 18, 2014, 05:17 PM |
| Ashton Paul | President & CEO | Jun 17, 2014 | Option Exercise | $1.13 | 4,500 | 5,085 | 445,241 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 16, 2014 | Option Exercise | $1.13 | 3,200 | 3,616 | 443,941 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 17, 2014 | Sale | $4.00 | 4,500 | 18,000 | 440,741 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 16, 2014 | Sale | $4.01 | 3,200 | 12,832 | 440,741 | Jun 18, 2014, 05:11 PM |
| Ashton Paul | President & CEO | Jun 13, 2014 | Option Exercise | $1.13 | 2,200 | 2,486 | 442,941 | Jun 16, 2014, 03:04 PM |
| Ashton Paul | President & CEO | Jun 12, 2014 | Option Exercise | $1.13 | 9,600 | 10,848 | 450,341 | Jun 16, 2014, 03:04 PM |
| Ashton Paul | President & CEO | Jun 12, 2014 | Sale | $4.02 | 9,600 | 38,592 | 440,741 | Jun 16, 2014, 03:04 PM |
| Ashton Paul | President & CEO | Jun 13, 2014 | Sale | $4.01 | 2,200 | 8,822 | 440,741 | Jun 16, 2014, 03:04 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 13, 2014 | Option Exercise | $1.81 | 2,100 | 3,801 | 98,523 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 12, 2014 | Option Exercise | $1.81 | 9,600 | 17,376 | 106,023 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 13, 2014 | Sale | $4.01 | 2,100 | 8,421 | 96,423 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | Jun 12, 2014 | Sale | $4.02 | 9,600 | 38,592 | 96,423 | Jun 16, 2014, 02:49 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | May 05, 2014 | Option Exercise | $1.81 | 3,500 | 6,335 | 99,923 | May 07, 2014, 07:21 PM |
| Freedman Lori | VP Corp. Affairs, GC and Sec | May 05, 2014 | Sale | $4.01 | 3,500 | 14,035 | 96,423 | May 07, 2014, 07:21 PM |
| Ashton Paul | President & CEO | May 05, 2014 | Option Exercise | $1.13 | 3,500 | 3,955 | 444,241 | May 07, 2014, 07:15 PM |
| Ashton Paul | President & CEO | May 05, 2014 | Sale | $4.01 | 3,500 | 14,035 | 440,741 | May 07, 2014, 07:15 PM |
| Hopper Paul | Director | Oct 01, 2012 | Buy | $1.67 | 10,000 | 16,750 | 10,000 | Oct 09, 2012, 12:08 PM |
| Hopper Paul | Director | Oct 01, 2012 | Buy | $1.62 | 10,000 | 16,150 | 10,000 | Oct 03, 2012, 07:36 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Cormorant Asset Management, LP | 10% Owner | 04/18/2024 | 10,489,446 |
| Paggiarino Dario A. | Chief Medical Officer | 03/30/2024 | 528,036 |
| Lurker Nancy | Executive Vice Chair | 02/09/2024 | 430,358 |
| Paggiarino Dario A. | Chief Medical Officer | 02/09/2024 | 146,390 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/09/2024 | 105,293 |
| Elston George | Chief Financial Officer | 02/09/2024 | 91,930 |
| Duker Jay S. | President and CEO | 02/09/2024 | 101,750 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/02/2024 | 2,397 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/02/2024 | 5,954 |
| Paggiarino Dario A. | Chief Medical Officer | 01/26/2024 | 644,047 |
| Paggiarino Dario A. | Chief Medical Officer | 01/26/2024 | 1,265,539 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/26/2024 | 177,398 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/26/2024 | 660,370 |
| Paggiarino Dario A. | Chief Medical Officer | 01/25/2024 | 7,809 |
| Paggiarino Dario A. | Chief Medical Officer | 01/25/2024 | 15,000 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/24/2024 | 90,822 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/25/2024 | 4,848 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/25/2024 | 15,000 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/24/2024 | 282,621 |
| Paggiarino Dario A. | Chief Medical Officer | 01/24/2024 | 146,426 |
| Paggiarino Dario A. | Chief Medical Officer | 01/23/2024 | 66,954 |
| Paggiarino Dario A. | Chief Medical Officer | 01/24/2024 | 281,415 |
| Paggiarino Dario A. | Chief Medical Officer | 01/23/2024 | 128,375 |
| Lurker Nancy | Executive Vice Chair | 01/24/2024 | 748,250 |
| Lurker Nancy | Executive Vice Chair | 01/23/2024 | 125,950 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/23/2024 | 6,790 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/22/2024 | 353,359 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/23/2024 | 22,500 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/22/2024 | 772,691 |
| Ocumension Therapeutics | Director | 01/11/2024 | 37,159,226 |
| Liu Ye | Director | 01/11/2024 | 37,159,226 |
| Cormorant Asset Management, LP | 10% Owner | 01/11/2024 | 14,812,500 |
| Cormorant Asset Management, LP | 10% Owner | 01/09/2024 | 2,238,600 |
| Paggiarino Dario A. | Chief Medical Officer | 01/08/2024 | 74,696 |
| Paggiarino Dario A. | Chief Medical Officer | 01/08/2024 | 484,124 |
| Paggiarino Dario A. | Chief Medical Officer | 01/06/2024 | 91,535 |
| Lurker Nancy | Executive Vice Chair | 01/06/2024 | 470,077 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 01/06/2024 | 121,706 |
| Jones David Scott | SVP & Chief Commercial Officer | 01/06/2024 | 84,599 |
| Duker Jay S. | President and CEO | 01/06/2024 | 133,171 |
| Elston George | Chief Financial Officer | 01/06/2024 | 100,184 |
| Paggiarino Dario A. | Chief Medical Officer | 12/13/2023 | 14,770 |
| Paggiarino Dario A. | Chief Medical Officer | 12/13/2023 | 29,160 |
| Cormorant Asset Management, LP | 10% Owner | 12/08/2023 | 9,999,995 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 567,900 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 1,010,790 |
| Ocumension Therapeutics | Director | 12/06/2023 | 4,901,515 |
| Ocumension Therapeutics | Director | 12/05/2023 | 14,609,122 |
| Liu Ye | Director | 12/06/2023 | 4,901,515 |
| Liu Ye | Director | 12/05/2023 | 14,609,122 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 567,900 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 12/04/2023 | 990,000 |
| Paggiarino Dario A. | Chief Medical Officer | 12/04/2023 | 310,231 |
| Paggiarino Dario A. | Chief Medical Officer | 12/04/2023 | 673,750 |
| Lurker Nancy | Executive Vice Chair | 12/04/2023 | 415,200 |
| Cormorant Asset Management, LP | 10% Owner | 12/04/2023 | 41,874,150 |
| EW Healthcare Partners, L.P. | 10% Owner | 09/01/2023 | 197,982 |
| EW Healthcare Partners, L.P. | 10% Owner | 09/01/2023 | 197,982 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/31/2023 | 804,061 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/30/2023 | 666,147 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/29/2023 | 944,225 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/28/2023 | 712,653 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/25/2023 | 931,327 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/24/2023 | 1,556,155 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/25/2023 | 931,479 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/24/2023 | 2,036,093 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/23/2023 | 1,580,915 |
| EW Healthcare Partners, L.P. | 10% Owner | 08/22/2023 | 683,834 |
| Liu Ye | Director | 05/30/2023 | 6 |
| Paggiarino Dario A. | Chief Medical Officer | 02/09/2023 | 15,612 |
| Duker Jay S. | President and COO | 02/09/2023 | 17,297 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/09/2023 | 12,327 |
| Duker Jay S. | Chief Operating Officer | 11/01/2022 | 24,276 |
| Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 03/14/2022 | 12,210 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/28/2022 | 11,243 |
| Paggiarino Dario A. | Chief Medical Officer | 02/28/2022 | 12,875 |
| Elston George | Chief Financial Officer | 02/09/2022 | 17,434 |
| Paggiarino Dario A. | Chief Medical Officer | 02/09/2022 | 17,434 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/09/2022 | 14,921 |
| Lurker Nancy | President & CEO | 11/15/2021 | 201,480 |
| Paggiarino Dario A. | Chief Medical Officer | 02/28/2021 | 15,383 |
| Jones David Scott | SVP & Chief Commercial Officer | 02/28/2021 | 18,399 |
| Elston George | Chief Financial Officer | 09/04/2020 | 4,800 |
| Elston George | Chief Financial Officer | 08/24/2020 | 6,112 |
| Jones David Scott | SVP & Chief Commercial Officer | 06/30/2020 | 10,643 |
| Paggiarino Dario A. | Chief Medical Officer | 06/30/2020 | 9,121 |
| Paggiarino Dario A. | Chief Medical Officer | 06/27/2020 | 2,317 |
| Paggiarino Dario A. | Chief Medical Officer | 06/14/2020 | 3,441 |
| Elston George | Chief Financial Officer | 03/12/2020 | 9,600 |
| Lurker Nancy | President & CEO | 03/10/2020 | 104,027 |
| Elston George | Chief Financial Officer | 11/15/2019 | 14,290 |
| Lurker Nancy | President & CEO | 10/12/2019 | 22,618 |
| Paggiarino Dario A. | Chief Medical Officer | 10/12/2019 | 5,157 |
| Mazzo David J | Director | 10/09/2019 | 64,999 |
| Ross Leonard S | See Remarks | 06/27/2019 | 3,236 |
| Paggiarino Dario A. | Chief Medical Officer | 06/27/2019 | 4,851 |
| Ross Leonard S | See Remarks | 06/14/2019 | 3,663 |
| Paggiarino Dario A. | Chief Medical Officer | 06/14/2019 | 6,388 |
| Landis John B. | Director | 05/13/2019 | 69,600 |
| Duker Jay S. | Director | 04/12/2019 | 35,400 |
| Duker Jay S. | Director | 04/01/2019 | 9,450 |
| Ross Leonard S | See Remarks | 04/01/2019 | 9,050 |
| Lurker Nancy | President & CEO | 03/29/2019 | 50,246 |
| Mazzo David J | Director | 03/29/2019 | 35,400 |
| Godshall Douglas Evan | Director | 03/29/2019 | 29,784 |
| Paggiarino Dario A. | Chief Medical Officer | 03/19/2019 | 2,934 |
| Ross Leonard S | See Remarks | 03/19/2019 | 4,285 |
| Ross Leonard S | See Remarks | 12/22/2018 | 30,561 |
| ROGERS MICHAEL W | Director | 11/15/2018 | 113,000 |
| Ross Leonard S | See Remarks | 10/12/2018 | 9,512 |
| Paggiarino Dario A. | Chief Medical Officer | 10/12/2018 | 7,930 |
| EW Healthcare Partners, L.P. | 10% Owner | 06/25/2018 | 825,089 |
| EW Healthcare Partners, L.P. | 10% Owner | 06/25/2018 | 20,507,955 |
| Ross Leonard S | See Remarks | 06/27/2018 | 3,541 |
| Paggiarino Dario A. | Chief Medical Officer | 06/27/2018 | 5,478 |
| Mazzo David J | Director | 04/20/2018 | 135,600 |
| EW Healthcare Partners, L.P. | 10% Owner | 03/28/2018 | 366,149 |
| EW Healthcare Partners, L.P. | 10% Owner | 03/28/2018 | 9,100,807 |
| Lurker Nancy | President and CEO | 06/14/2017 | 99,962 |
| Ashton Paul | President & CEO | 03/18/2016 | 11,300 |
| Ross Leonard S | Vice President, Finance | 01/04/2016 | 9,050 |
| Ross Leonard S | Vice President, Finance | 01/04/2016 | 23,500 |
| Ross Leonard S | Vice President, Finance | 12/22/2015 | 61,449 |
| Ross Leonard S | Vice President, Finance | 12/22/2015 | 182,990 |
| Ashton Paul | President & CEO | 12/22/2015 | 135,600 |
| Ashton Paul | President & CEO | 12/22/2015 | 646,800 |
| Ross Leonard S | Vice President, Finance | 12/01/2015 | 1,900 |
| Ross Leonard S | Vice President, Finance | 12/01/2015 | 4,263 |
| Ross Leonard S | Vice President, Finance | 08/03/2015 | 9,050 |
| Ross Leonard S | Vice President, Finance | 08/03/2015 | 20,250 |
| Ashton Paul | President & CEO | 10/01/2014 | 11,300 |
| Ashton Paul | President & CEO | 10/01/2014 | 42,700 |
| Ashton Paul | President & CEO | 09/02/2014 | 11,300 |
| Ashton Paul | President & CEO | 09/02/2014 | 47,800 |
| Ashton Paul | President & CEO | 08/01/2014 | 11,300 |
| Ashton Paul | President & CEO | 08/01/2014 | 43,700 |
| Ashton Paul | President & CEO | 07/01/2014 | 11,300 |
| Ashton Paul | President & CEO | 07/01/2014 | 43,200 |
| Ashton Paul | President & CEO | 06/18/2014 | 4,442 |
| Ashton Paul | President & CEO | 06/19/2014 | 3,468 |
| Ashton Paul | President & CEO | 06/18/2014 | 15,724 |
| Ashton Paul | President & CEO | 06/19/2014 | 12,276 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/16/2014 | 6,219 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/17/2014 | 8,080 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/17/2014 | 17,856 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/16/2014 | 13,778 |
| Ashton Paul | President & CEO | 06/17/2014 | 5,085 |
| Ashton Paul | President & CEO | 06/16/2014 | 3,616 |
| Ashton Paul | President & CEO | 06/17/2014 | 18,000 |
| Ashton Paul | President & CEO | 06/16/2014 | 12,832 |
| Ashton Paul | President & CEO | 06/13/2014 | 2,486 |
| Ashton Paul | President & CEO | 06/12/2014 | 10,848 |
| Ashton Paul | President & CEO | 06/12/2014 | 38,592 |
| Ashton Paul | President & CEO | 06/13/2014 | 8,822 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/13/2014 | 3,801 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/12/2014 | 17,376 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/13/2014 | 8,421 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 06/12/2014 | 38,592 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 05/05/2014 | 6,335 |
| Freedman Lori | VP Corp. Affairs, GC and Sec | 05/05/2014 | 14,035 |
| Ashton Paul | President & CEO | 05/05/2014 | 3,955 |
| Ashton Paul | President & CEO | 05/05/2014 | 14,035 |
| Hopper Paul | Director | 10/01/2012 | 16,750 |
| Hopper Paul | Director | 10/01/2012 | 16,150 |
Load More Insider Transactions
FUNDS WITH A POSITION IN EYEPOINT PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,466,420 | 0.21% | 157.21% | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,056,847 | 4.24% | 16.17% | Growth At A Reasonable Price |
| BLACKROCK INC. | 2,169,306 | 0.00128% | 18.58% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 682,417 | 0.00165% | 27.42% | Other |
| CANDRIAM S.C.A. | 140,000 | 0.02% | New | Other |
| D. E. SHAW & CO., INC. | 100,960 | 0.00204% | New | Other |
| AQR CAPITAL MANAGEMENT LLC | 24,268 | 0.00106% | 58.32% | Other |
| GOTHAM ASSET MANAGEMENT, LLC | 13,159 | 0.00564% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR EYEPOINT PHARMACEUTICALS INC
STOCK BUYBACKS FOR EYEPOINT PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
10.08%
1Q
06/30/2023
12.32%
2Q
03/31/2023
12.59%
3Q
12/31/2022
12.99%
4Q
09/30/2022
13.03%
5Q
06/30/2022
13.08%
6Q
03/31/2022
13.29%
7Q
12/31/2021
28.89%
8Q
09/30/2021
46.71%
9Q
06/30/2021
46.83%
10Q
03/31/2021
70.62%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR EYEPOINT PHARMACEUTICALS INC
LOADING...